ZWZhe Wang

Zhe Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhe Wang has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Zitong Wang

    Department of Pathology, Shengjing Hospital of China Medical University , No. 36 Sanhao Street, Shenyang, Liaoning 110004

    6 shared publications
  • Feng Zhao

    Department of Stem Cells and Regenerative Medicine , Shenyang Key Laboratory of Stem Cell and Regenerative Medicine No. 77 Puhe Road, Shenyang, Liaoning 110013

    5 shared publications
  • Xing Huang

    Department of Anaesthesiology, the First Affiliated Hospital of Xi'an Jiaotong University , No. 277 Yantaxi Road, Xi'an, Shanxi 710061

    4 shared publications
  • Cai He

    Department of Pathology, Shengjing Hospital of China Medical University , No. 36 Sanhao Street, Shenyang, Liaoning 110004

    3 shared publications
  • Chengcheng Xu

    Department of Pathology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang City, Liaoning Province, 110004, China

    3 shared publications
  • Haiyue Ren

    Department of Pathology, Wuhan Hospital of Traditional Chinese and Western Medicine (Wuhan No. 1 Hospital) , No. 215 Zhongshan Street, Wuhan, Hubei 430022

    3 shared publications

Latest Publications

  • Open Access

    Artificial intelligence for microsatellite instability detection in precision oncology: a systematic review from 2015 to 2025

    by Xin Geng, Fuyao Yu, Yuan Gao, Meixin Lu, Hong Li, Zhe Wang

    Microsatellite instability (MSI) and mismatch repair deficiency (dMMR) are clinically actionable biomarkers that guide immunotherapy selection and prognostic stratification across multiple solid tumors. Polymerase chain reaction (PCR), immunohistochemistry (IHC), and next-generation sequencing (NGS) remain reference standards for MSI/dMMR assessment. We conducted a systematic review of artificial intelligence (AI)-based approaches for MSI/dMMR detection, searching PubMed, IEEE Xplore, Springer, and ScienceDirect for studies first publicly available between January 2015 and December 2025. Study selection followed PRISMA guidelines, and risk of bias was assessed using QUADAS-2. Of 1589 records, 111 studies were included after full-text review, hierarchically sorted by validation strategy (prioritizing independent external validation), cohort size, and performance metrics. AI-based prediction has been evaluated across histopathology whole-slide images (WSIs), radiology, omics, endoscopy, clinical variables, and multimodal combinations. Deep learning applied to H&E WSIs is the most extensively studied approach, although external validation remains inconsistent. Multimodal models are promising, but superiority over single-modality models remains unproven. Most studies predict assay-defined MSI/dMMR rather than treatment outcomes; the available evidence does not yet support routine clinical use of AI for triage or assay replacement. Prospective multicenter trials should evaluate AI-derived phenotypes as complementary or standalone biomarkers for treatment selection.

  • Open Access

    Hypoxic preconditioning drives metabolic reprogramming to increase the therapeutic efficacy of adipose mesenchymal stem cells in diabetic wounds

    by Haiyue Ren, Hankun Cao, Cai He, Qiqi Zhang, Yuge Wang, Baoling Tian, Chengcheng Xu, Yan Feng, Zhe Wang

    Hypoxic pretreatment improves the efficacy of adipose-derived mesenchymal stem cells (ADSCs) in the repair of chronic refractory wounds; however, the underlying molecular mechanisms remain poorly understood. Energy metabolism serves as a crucial regulatory factor that influences stem cell fate, proliferation, and self-renewal capabilities. In this study, we established a diabetic skin wound model to systematically investigate the effects of the diabetic microenvironment and hypoxic pretreatment on the energy metabolism and functions of ADSCs, aiming to elucidate the role of adaptive metabolic regulation in increasing stem cell survival rates following transplantation. An in vitro diabetic cell model was established to systematically evaluate the effects of high glucose and hypoxic preconditioning on the proliferation, migration, apoptosis, and cytokine secretion of ADSCs via PCR analysis and CCK-8, cell scratch, and apoptosis assays. The impact of high glucose and hypoxic preconditioning on the energy metabolism characteristics of ADSCs was investigated with a Seahorse XF Analyzer. The regulatory effects of the mTOR/HIF-1α signalling pathway on the energy metabolism and cellular functions of ADSCs was investigated via mTOR pathway inhibitors and siHIF transfection. The therapeutic efficacy of hypoxia preconditioned ADSCs in diabetic wound healing was determined by calculating wound healing rates and performing histopathological analyses. Hypoxic preconditioning alleviated high glucose-induced functional impairments in ADSCs, including enhanced cell proliferation, migration, and cytokine secretion capacity, along with reduced apoptosis. Seahorse XF analysis revealed that high-glucose conditions suppressed glycolytic activity and impaired mitochondrial function, whereas hypoxic preconditioning upregulated glycolytic flux and optimized mitochondrial energy metabolism. Notably, cotreatment with mTOR pathway inhibitors or HIF-1α-targeting siRNA attenuated the beneficial effects of hypoxic preconditioning, particularly its regulatory impact on energy metabolism profiles. In vivo experiments confirmed that hypoxic-preconditioned ADSCs significantly improved therapeutic outcomes in diabetic skin wounds. However, these therapeutic enhancements were reversed upon coadministration of mTOR pathway inhibitors. The hyperglycaemic microenvironment in diabetic wounds disrupts cellular energy metabolism, while hypoxic preconditioning enhances the therapeutic efficacy of ADSCs in promoting diabetic wound repair by activating the mTOR/HIF-1α signalling pathway to remodel their energy metabolic profile.


  • Open Access

    Hydrogel-mediated sequestration of ADSC angiogenic signals promotes vascularized tissue regeneration

    by Yiwei Wang, Nanan Xue, Ziyu Wang, Ziyi Zhou, Meiqing Yang, Yangyu Song, Qing Xia, Yuge Wang, Ali Fathi, Simin Maleknia, et al.

    Adipose-derived stem cells spheroids (ADSC3D) represent a promising strategy for tissue regeneration, but their clinical translation is limited by insufficient vascularization due to a rapid loss of endogenous bioactive factors. Here, we addressed this challenge using a thermosensitivem, injetable, N-acryloxysuccinimide functionalized PNPHO hydrogel that can locally sequesters pro-angiogenic growth factors secreted by encapsulated ADSC3D. In a subcutaneous fat grafting model, the PNPHO-ADSC3D system supported robust, sustained neovascularization with large, continuous, and mature adipose tissue regeneration. This synergistic strategy establishes a pro-angiogenic and regenerative microenvironment and offers a growth factor-free, versatile, and clinically adaptable platform for vascularized tissue regeneration.

  • Open Access

    Organoids in skin wound healing

    by Zitong Wang, Feng Zhao, Hongxin Lang, Haiyue Ren, Qiqi Zhang, Xing Huang, Cai He, Chengcheng Xu, Chiyu Tan, Jiajie Ma, et al.

    Stem cells (SCs) can self-replicate and differentiate into multiple lineages. Organoids, 3D cultures derived from SCs, can replicate the spatial structure and physiological characteristics of organs in vitro. Skin organoids can effectively simulate the physiological structure and function of skin tissue, reliably restoring the natural skin ecology in various in vitro environments. Skin organoids have been employed extensively in skin development and pathology research, offering valuable insights for drug screening. Moreover, they play crucial roles in skin regeneration and tissue repair. This in-depth review explores the construction and applications of skin organoids in wound healing, with a focus on their construction process, including skin appendage integration, and significant advancements in wound-healing research.


  • Open Access

    Single-cell sequencing technology in skin wound healing

    by Xu Cheng Cheng, Wang Zi Tong, Wang Rui, Zhao Feng, Hou Shuai, Wang Zhe

    Skin wound healing is a complicated biological process that mainly occurs in response to injury, burns, or diabetic ulcers. It can also be triggered by other conditions such as dermatitis and melanoma-induced skin cancer. Delayed healing or non-healing after skin injury presents an important clinical issue; therefore, further explorations into the occurrence and development of wound healing at the cellular and molecular levels are necessary. Single-cell sequencing (SCS) is used to sequence and analyze the genetic messages of a single cell. Furthermore, SCS can accurately detect cell expression and gene sequences. The use of SCS technology has resulted in the emergence of new concepts pertaining to wound healing, making it an important tool for studying the relevant mechanisms and developing treatment strategies. This article discusses the application value of SCS technology, the effects of the latest research on skin wound healing, and the value of SCS technology in clinical applications. Using SCS to determine potential biomarkers for wound repair will serve to accelerate wound healing, reduce scar formation, optimize drug delivery, and facilitate personalized treatments.


  • Open Access

    Adipose mesenchymal stem cell-derived exosomes promote skin wound healing in diabetic mice by regulating epidermal autophagy

    by Haiyue Ren, Peng Su, Feng Zhao, Qiqi Zhang, Xing Huang, Cai He, Quan Wu, Zitong Wang, Jiajie Ma, Zhe Wang

    Adipose mesenchymal stem cell-derived exosomes (ADSC-Exos) have great potential in the field of tissue repair and regenerative medicine, particularly in cases of refractory diabetic wounds. Interestingly, autophagy plays a role in wound healing, and recent research has demonstrated that exosomes are closely associated with intracellular autophagy in biogenesis and molecular signaling mechanisms. Therefore, this study aimed to investigate whether ADSC-Exos promote the repair of diabetic wounds by regulating autophagy to provide a new method and theoretical basis for the treatment of diabetic wounds. Western blot analysis and autophagy double-labelled adenovirus were used to monitor changes in autophagy flow in human immortalized keratinocyte cell line (HaCaT) cells. ADSC-Exos were generated from ADSC supernatants via ultracentrifugation. The effectiveness of ADSC-Exos on HaCaT cells was assessed using a live-cell imaging system, cell counting kit-8 and cell scratch assays. The cells were treated with the autophagy inhibitor bafilomycin A1 to evaluate the effects of autophagy on cell function. The recovery of diabetic wounds after ADSC-Exo treatment was determined by calculating the healing rates and performing histological analysis. High-throughput transcriptome sequencing was used to analyze changes in mRNA expression after the treatment of HaCaT cells with ADSC-Exos. ADSC-Exos activated autophagy in HaCaT cells, which was inhibited by high glucose levels, and potentiated their cellular functions. Moreover, ADSC-Exos in combination with the autophagy inhibitor bafilomycin A1 showed that autophagy defects further impaired the biological function of epidermal cells under high-glucose conditions and partially weakened the healing effect of ADSC-Exos. Using a diabetes wound model, we found that ADSC-Exos promoted skin wound healing in diabetic mice, as evidenced by increased epidermal autophagy and rapid re-epithelialization. Finally, sequencing results showed that increased expression of autophagy-related genes nicotinamide phosphoribosyltransferase (NAMPT), CD46, vesicle-associated membrane protein 7 (VAMP7), VAMP3 and eukaryotic translation initiation factor 2 subunit alpha (EIF2S1) may contribute to the underlying mechanism of ADSC-Exo action. This study elucidated the molecular mechanism through which ADCS-Exos regulate autophagy in skin epithelial cells, thereby providing a new theoretical basis for the treatment and repair of skin epithelial damage by ADSC-Exos.


  • Top Cited Papers
    Open Access

    Metabolic reprogramming in skin wound healing

    by Zitong Wang, Feng Zhao, Chengcheng Xu, Qiqi Zhang, Haiyue Ren, Xing Huang, Cai He, Jiajie Ma, Zhe Wang

    Metabolic reprogramming refers to the ability of a cell to alter its metabolism in response to different stimuli and forms of pressure. It helps cells resist external stress and provides them with new functions. Skin wound healing involves the metabolic reprogramming of nutrients, such as glucose, lipids, and amino acids, which play vital roles in the proliferation, differentiation, and migration of multiple cell types. During the glucose metabolic process in wounds, glucose transporters and key enzymes cause elevated metabolite levels. Glucose-mediated oxidative stress drives the proinflammatory response and promotes wound healing. Reprogramming lipid metabolism increases the number of fibroblasts and decreases the number of macrophages. It enhances local neovascularization and improves fibrin stability to promote extracellular matrix remodelling, accelerates wound healing, and reduces scar formation. Reprogramming amino acid metabolism affects wound re-epithelialization, collagen deposition, and angiogenesis. However, comprehensive reviews on the role of metabolic reprogramming in skin wound healing are lacking. Therefore, we have systematically reviewed the metabolic reprogramming of glucose, lipids, and amino acids during skin wound healing. Notably, we identified their targets with potential therapeutic value and elucidated their mechanisms of action.


  • Open Access

    Protein and transcript expression levels of TRIP13 signify worse prognosis in endometrioid carcinoma

    by Quan Wu, Zitong Wang, Cai He, Jingwei Guo, Chengcheng Xu, Yehan Gao, Yichen Zhang, Jiajie Ma, Zhe Wang

    This study investigated the genes implicated in endometrioid adenocarcinoma development to provide insights into the molecular diagnosis, targeted therapy, and prognostic prediction of the disease. Two mRNA microarray datasets were obtained from the Gene Expression Omnibus. Differentially expressed genes were identified, and a protein–protein interaction network was constructed. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed on the genes within the network modules. Prognostic significance was determined through a survival analysis to identify the key genes. The UALCAN website was used to validate TRIP13 mRNA expression, and immunohistochemical staining was performed to evaluate TRIP13 protein expression in patient samples. Sixteen genes were significantly associated with patient prognosis. The results revealed significantly elevated TRIP13 transcription and protein expression levels in endometrial cancer tissues compared to those in normal tissues. High TRIP13 expression was significantly correlated with shorter survival and considered an independent risk factor for endometrioid adenocarcinoma. Further, a negative correlation between TRIP13 expression and infiltrating CD8 + T cell levels in uterine corpus endometrial carcinoma was observed. This study validated the correlation between TRIP13 expression and poor patient prognosis, suggesting that TRIP13 may be a biomarker for endometrioid adenocarcinoma prognosis predictions.


  • Open Access

    Characterization of a Human Gastrointestinal Stromal Tumor Cell Line Established by SV40LT-Mediated Immortalization

    by Xiangchen Hu, Peng Su, Bo Liu, Jingwei Guo, Zitong Wang, Cai He, Zhe Wang, Youwei Kou

    Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the digestive tract and originate from the interstitial cells of Cajal (ICC), which is the pacemaker for peristaltic movement in the gastrointestinal tract. Existing GIST cell lines are widely used as cell models for in vitro experimental studies because the mutation sites are known. However, the immortalization methods of these cell lines are unknown, and no Chinese patient-derived GIST cell lines have been documented. Here, we transfected simian virus 40 large T antigen (SV40LT) into primary GIST cells to establish an immortalized human GIST cell line (ImGIST) for the first time. The ImGIST cells had neuronal cell-like irregular radioactive growth and retained the fusion growth characteristics of GIST cells. They stably expressed signature proteins, maintained the biological and genomic characteristics of normal primary GIST cells, and responded well to imatinib, suggesting that ImGIST could be a potential in vitro model for research in GIST to explore the molecular pathogenesis, drug resistance mechanisms, and the development of new adjuvant therapeutic options.